MSB 3.83% $1.26 mesoblast limited

Ann: Mesoblast to Evaluate Remestemcel-L in COVID-19 Lung Disease, page-31

  1. 424 Posts.
    lightbulb Created with Sketch. 30
    After I read announcement, it is believed that MSB products will be positive for this virus.
    Especially in this critical timing, it will give people confident.
    Hope products can be pushed to FDA fast track.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.26
Change
-0.050(3.83%)
Mkt cap ! $1.432B
Open High Low Value Volume
$1.27 $1.30 $1.17 $18.41M 14.90M

Buyers (Bids)

No. Vol. Price($)
20 147916 $1.25
 

Sellers (Offers)

Price($) Vol. No.
$1.26 46329 18
View Market Depth
Last trade - 15.12pm 24/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.